Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Underestimated Metropolitan Experience Urban communities On the planet - 2Former 'Bachelorette' welcomes 1st baby via emergency c-section
- 3Embrace Effortlessness: Moderation and Cleaning up Tips
- 4Rediscovering Euphoria: Individual Accounts of Conquering Despondency
- 5Extraordinary Picks for Home Apparatuses: Making Life Simpler
- Vote in favor of your Number one Kind of Gems
- The Best Cell phone Brands for Tech Lovers
- Flu season is just beginning, but doctors are already on high alert
- Native artists in Texas and Mexico shared their vision of the universe for 4,000 years, ancient murals suggest
- Unpaid caregiving work can feel small and personal, but that doesn’t take away its ethical value
- Will your baby get a hep B vaccine? What RFK panel's ruling means.
- Step by step instructions to Analyze Senior Insurance Contracts Really.
- The Best 15 Applications for Efficiency and Association
- Best Veggie lover Dinner: What's Your Plant-Based Pick?
